ACEM Fellowship
Paediatric Urinary Tract Infection

Paediatric Urinary Tract Infection

Introduction

  • 3% of infants will suffer UTI in first 2 years of life
  • 10% of girls have UTI by adulthood, mostly after first 2 years of life
  • 2-3% of boys have UTI by adulthood, 60% when under 2 years old
  • VUR is present in 20-30% of children with first UTI (vs. 2-3% general paediatric population)
  • Recurrence rate 15-40%
    • Risk factors include younger age at 1st diagnosis, VUR and voiding dysfunction
  • More common in male neonates but then female preponderance continues lifelong
  • Neonates may develop UTI through haematogenous spread
  • More likely to have first-degree relative with hx of UTI
  • Renal involvement associated with:
    • Age <1 year
    • Symptoms >5 days
    • Systemic upset, fever, leukocytosis
    • Presence of VUR or other anatomical abnormality

Which sample?

  • Void on request – MSU
    • Wash genitalia with water and pat dry
    • Pure growth >108 CFU/litre indicates infection
    • Pure growth >105 CFU/litre indicates early infection and specimen should be repeated
  • Younger children – Clean catch
    • Wash genitalia with water and pat dry first
  • Septic infants – SPA or in/out catheter if SPA fails
    • Any growth from SPA indicates infection
    • Any growth >103 CFU/litre probably indicates infection
    • >5 WBC/HPF or >10 WBC/microlitre suggests infection

Suprapubic aspirate

  • Bedside USS to confirm urine in bladder first
  • Indications
    • Young unwell infants in whom specimen is required without delay in order to provide antibiotics
    • Child <2yo when deemed important to confirm UTI
    • Children with previous UTI’s with unusual or resistant organisms
    • Children on prophylactic antibiotics
  • Contraindications
    • Bleeding diathesis
    • Abdominal distension
    • Massive organomegaly
  • 23G (25G for premature infants) needle
  • Oral sucrose for <3mo/EMLA if not urgent in >3mo
  • Hold infant supine with legs extended (squeeze shaft of penis to occlude urethra)
  • Midline lower abdominal crease insertion point. Perpendicular to skin. Insert to hub of needle and aspirate while drawing back

What is the role of urinary dipstick?

  • Screening test only and if UTI is suspected, should be sent for MCS anyway
  • Poor specificity and sensitivity, especially in children <3yo
    • Sensitivity 85-90% (high false-negative rate of up to 20% so should not be used as a rule out test)
    • Also false positives from sterile pyuria are common
  • Nitrites only present if bacteria convert nitrates to nitrites and take time to develop in urine. Poor sensitivity
  • Blood and protein are unreliable indicators of UTI
  • Very young and neutropaenic patients may not have pyuria. Poorly sensitive as need quite a high WCC for leukocyte esterase to be positive
  • Leukocytes from other sources e.g. vagina can contaminate sample and appear in the urine in the setting of other febrile illnesses. Poorly specific
  • Urinalysis may be normal in 50% of infants <8 weeks old with UTI

Bag specimens

  • Not reliable for exclusion or diagnosis
  • 60% false positive rate and 15% false negative rate

NICE guideline

  • Urine samples should be sent for culture if:
    • Suspected pyelonephritis
    • Intermediate to high risk of serious illness
    • Infants under 3 mo
    • Positive leukocyte esterase and/or nitrite
    • Recurrent UTI
    • Not responding to treatment within 48 hours and not already sent
    • Clinical symptoms and dipstick tests do not correlate
  • If leukocyte negative, nitrite positive – treat and send MCS
  • If leukocyte positive, nitrite negative – Send MCS and hold off Rx
  • If both negative – look for alternative source. Do not treat.
  • Bacteriuria positive
    • Treat even if leukocyte negative
  • Bacteriuria negative
    • Treat if leukocyte positive and clinically UTI
    • Do not treat if leukocyte negative

Definitions

  • Atypical UTI
    • Seriously ill
    • Poor urine flow
    • Abdominal or bladder mass
    • Raised creatinine
    • Septicaemia
    • Failure to respond within 48 hours
    • Infection with non-E. coli organisms
  • Recurrent UTI
    • 2 or more episodes of pyelonephritis
    • 1 episode of pyelonephritis with 1 or more episodes of cystitis
    • 3 or more episodes of cystitis

NICE guidelines: Imaging <6mo

TestResponds well within 48 hoursAtypical UTIRecurrent UTI
USS during acute infectionNoYes (within 6 weeks if just non-E.coli but otherwise responding well)Yes
USS within 6 weeksYesNoNo
DMSA 4-6 months after acute infectionNoYesYes
MCUGNoYesYes

NICE guideline: Imaging 6mo to 3yo

TestResponds well within 48 hoursAtypical UTIRecurrent UTI
USS during acute infectionNoYes (within 6 weeks if just non-E.coli but otherwise responding well)No
USS within 6 weeksNoNoYes
DMSA 4-6 months after acute infectionNoYesYes
MCUG  – Can consider if dilatation on USS, poor urine flow, non-E.coli infection or FHx of VURNoNoNo

NICE Guideline: Imaging >3yo

TestResponds well within 48 hoursAtypical UTIRecurrent UTI
USS during acute infectionNoYes (within 6 weeks if just non-E.coli but otherwise responding well)No
USS within 6 weeksNoNoYes
DMSA 4-6 months after acute infectionNoNoYes
MCUGNoNoNo

Treatment (QCH guideline)

  • Oral therapy
    • Bactrim 4mg/kg PO BD for 5 days
  • IV therapy
    • Ampicillin 50mg/kg q6h + Gentamicin 7.5mg/kg (10mg/kg if >10yo) once daily
  • Cameron suggests 10 days for infants up to 12 months, 5-10 days for pre-school age children and as short as 3 days in older children who are well

When to consult paediatrics and follow-up

  • Consult
    • Child <6 mo
    • Known renal tract abnormalities
    • Severely unwell
  • Follow-up
    • Atypical UTI, not responding within 48 hours, boys <3 mo should have renal tract USS ASAP to exclude obstruction
    • <6mo should have renal USS within 6 weeks of Dx or during illness if atypical or not responding within 48 hours
    • Recurrent UTI should have renal USS
    • Asymptomatic bacteriuria is not an indication for follow-up
    • Urine re-testing is not necessary after treatment for a UTI if asymptomatic now (although Cameron recommends this, NICA guideline does not)

Prognosis

  • 10-20% of children with VUR and scars develop HTN during childhood
  • 34% of adults with reflux nephropathy are hypertensive
  • 30-50% of children with VUR have scarring at initial evaluation
  • 5-15% of adults with ESRF <50yo is due to reflux nephropathy
  • Prevention
    • Good fluid intake, complete voiding, avoiding constipation, cranberry juice may have some benefit

Microscopic haematuria

  • Common in UTI (or any febrile illness) and urine should be tested once acute illness passed
  • Asymptomatic microscopic haematuria without other signs of renal disease (i.e. casts, HTN, proteinuria, oedema) is also relatively common

Proteinuria

  • Common in UTI, fever, exercise
  • If found, need to repeat urine after acute illness has passed to confirm presence
  • Always consider nephrotic range proteinuria (and its other sequelae)

Last Updated on November 9, 2021 by Andrew Crofton